INS and type 1 diabetes mellitus: <b>Research Design and Methods</b>: In this prospective, multicenter observational study, adults with T1DM transitioned from MDI or open-loop continuous subcutaneous insulin infusion to OP5<sup>®</sup> and were followed for 180 days.